REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

Vlad Ratziu*, Arun J. Sanyal, Rohit Loomba, Mary Rinella, Stephen Harrison, Quentin M. Anstee, Zachary Goodman, Pierre Bedossa, Leigh MacConell, Reshma Shringarpure, Amrik Shah, Zobair Younossi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

91 Scopus citations

Fingerprint

Dive into the research topics of 'REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science